HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists re-engineer Patient's own cells to hunt lymphoma
Disease control OngoingThis early-phase study is testing the safety of a new cell therapy for patients with Hodgkin's or Non-Hodgkin's lymphoma that has come back after standard treatment. Doctors collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack lymp…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug trial targets Tough-to-Treat rare cancers
Disease control TerminatedThis study is testing an experimental drug called XmAb20717 in adults with advanced rare cancers that have few treatment options. The main goals are to see if the drug is safe and if it can shrink tumors or slow their growth. The trial is currently suspended and is not enrolling …
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Can better doctor talk ease the cancer survivor journey?
Knowledge-focused OngoingThis study aims to see if training doctors in communication skills helps patients who have finished treatment for Hodgkin's or Diffuse Large B-cell Lymphoma transition into survivorship. It involves 314 participants, including doctors and their patients who are in remission. The …
Matched conditions: HODGKIN'S LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC